View of Characterisation of mutations in cytogenetically normal acute myeloid leukaemia patients with triple-negative FLT3-ITD/ NPM1/CEBPA subgroup using targeted next-generation sequencing

Return to Issue Details Characterisation of mutations in cytogenetically normal acute myeloid leukaemia patients with triple-negative FLT3-ITD/ NPM1/CEBPA subgroup using targeted next-generation sequencing Download Download PDF